(MedPage Today) — The FDA approved the combination of bictegravir and lenacapavir (Bixlenvo) for adults with virologically suppressed HIV-1 infection, Gilead Sciences announced Thursday.
The once-daily single tablet contains 75 mg of the integrase…
Source link
Bictegravir-Lenacapavir Combo Pill Earns FDA Approval in Suppressed HIV
Show Comments (0)
Hide Comments (0)
0
0
votes
Article Rating
Subscribe
Login
0 Comments
Oldest
Newest
Most Voted
Inline Feedbacks
View all comments
